{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T01:20:15Z","timestamp":1788484815170,"version":"build-2803163510"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T00:00:00Z","timestamp":1779753600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","award":["RSV00105"],"award-info":[{"award-number":["RSV00105"]}],"id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014588","name":"Sanofi Pasteur SA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014588","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014088","name":"AstraZeneca France","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014088","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.vaccine.2026.128773","type":"journal-article","created":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T03:38:45Z","timestamp":1780025925000},"page":"128773","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Residual burden of severe RSV disease in infants during the first season of maternal RSVpreF immunization in Argentina: A hospital-based, multicentre, retrospective cohort study"],"prefix":"10.1016","volume":"87","author":[{"given":"Julia","family":"Dvorkin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Pico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gonzalo","family":"Gui\u00f1az\u00fa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Sol","family":"Crespi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shona","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosario","family":"Merlino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana","family":"Palau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celeste","family":"Samaruga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Esposto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micaela","family":"Pichinenda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasia","family":"Regalado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Torre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela Sanluis","family":"Fenelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Fabiana","family":"Ossorio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agustina","family":"Sbruzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stella Maris","family":"Souto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Ferrero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Ves","family":"Losada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Graziano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Nieves","family":"Ojeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvana","family":"Lugo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guadalupe","family":"Geli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00f3nica","family":"Schpilberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo","family":"Eymann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio","family":"Busaniche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauricio T.","family":"Caballero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2026.128773_bb0005","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1016\/S0140-6736(22)00478-0","article-title":"Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis","volume":"399","author":"Li","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2026.128773_bb0010","article-title":"Defining the vaccination window for respiratory syncytial virus (RSV) using age-seroprevalence data for children in Kilifi","volume":"12","author":"Nyiro","year":"2017","journal-title":"Kenya PLOS ONE"},{"key":"10.1016\/j.vaccine.2026.128773_bb0015","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/S0140-6736(10)60206-1","article-title":"Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis","volume":"375","author":"Nair","year":"2010","journal-title":"Lancet Lond Engl"},{"key":"10.1016\/j.vaccine.2026.128773_bb0020","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/S0140-6736(17)30938-8","article-title":"Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study","volume":"390","author":"Shi","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2026.128773_bb0025","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1016\/S0140-6736(22)00478-0","article-title":"Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis","volume":"399","author":"Li","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2026.128773_bb0030","series-title":"Semana Epidemiol\u00f3gica 1\u201352, a\u00f1o 2023","author":"de Salud","year":"2023"},{"key":"10.1016\/j.vaccine.2026.128773_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(24)01699-4","article-title":"Respiratory syncytial virus vaccination and immunoprophylaxis: realising the potential for protection of young children","author":"Pecenka","year":"2024","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.vaccine.2026.128773_bb0040","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1093\/cid\/ciad707","article-title":"Safety and Immunogenicity of Bivalent RSVpreF Vaccine Coadministered With Seasonal Inactivated Influenza Vaccine in Older Adults","volume":"78","author":"Athan","year":"2024","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2026.128773_bb0045","doi-asserted-by":"crossref","first-page":"S142","DOI":"10.1093\/cid\/ciw560","article-title":"Morbidity and Mortality Due to Bordetella pertussis: A Significant Pathogen in West Africa?","volume":"63","author":"Kampmann","year":"2016","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"10.1016\/j.vaccine.2026.128773_bb0050","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S1473-3099(24)00215-9","article-title":"Effectiveness and impact of universal prophylaxis with nirsevimab in infants against hospitalisation for respiratory syncytial virus in Galicia, Spain: initial results of a population-based longitudinal study","volume":"24","author":"Ares-G\u00f3mez","year":"2024","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2026.128773_bb0055","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1056\/NEJMc2214773","article-title":"Nirsevimab for Prevention of RSV in Term and Late-Preterm Infants","volume":"388","author":"Muller","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2026.128773_bb0060","first-page":"00233","article-title":"Effectiveness and impact of nirsevimab in Chile during the first season of a national immunisation strategy against RSV (NIRSE-CL): a retrospective observational study","volume":"S1473-3099(25)","author":"Torres","year":"2025","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2026.128773_bb0065","doi-asserted-by":"crossref","unstructured":"Marc GP, Vizzotti C, Fell DB, et al. Real-world effectiveness of RSVpreF vaccination during pregnancy against RSV-associated lower respiratory tract disease leading to hospitalisation in infants during the 2024 RSV season in Argentina (BERNI study): a multicentre, retrospective, test-negative, case\u2013control study. Lancet Infect Dis 2025; DOI:https:\/\/doi.org\/10.1016\/S1473-3099(25)00156-2.","DOI":"10.1016\/S1473-3099(25)00156-2"},{"key":"10.1016\/j.vaccine.2026.128773_bb0070","first-page":"52","article-title":"Impact and effectiveness of RSV maternal immunization on infant hospitalizations in Buenos Aires: a hospital-based, multicentre, retrospective surveillance cohort study","author":"Razzini","year":"2025","journal-title":"Lancet Reg Health \u2013 Am"},{"key":"10.1016\/j.vaccine.2026.128773_bb0075","first-page":"84","article-title":"Recommendations for palivizumab use. Update 2015","volume":"114","author":"de Estudios","year":"2016","journal-title":"Arch Argent Pediatr"},{"key":"10.1016\/j.vaccine.2026.128773_bb0080","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1080\/23288604.2018.1477537","article-title":"Making Universal Health Care Effective in Argentina: A Blueprint for Reform","volume":"4","author":"Rubinstein","year":"2018","journal-title":"Health Syst Reform"},{"key":"10.1016\/j.vaccine.2026.128773_bb0085","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.vaccine.2015.05.093","article-title":"WHO consultation on Respiratory Syncytial Virus Vaccine Development Report from a World Health Organization Meeting held on 23\u201324 March 2015","volume":"34","author":"Modjarrad","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.128773_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbi.2019.103208","article-title":"The REDCap consortium: Building an international community of software platform partners","volume":"95","author":"Harris","year":"2019","journal-title":"J Biomed Inform"},{"key":"10.1016\/j.vaccine.2026.128773_bb0095","doi-asserted-by":"crossref","first-page":"30547","DOI":"10.1073\/pnas.2013182117","article-title":"The impact of COVID-19 nonpharmaceutical interventions on the future dynamics of endemic infections","volume":"117","author":"Baker","year":"2020","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.vaccine.2026.128773_bb0100","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1186\/s13054-019-2522-6","article-title":"Health inequities in the diagnosis and outcome of sepsis in Argentina: a prospective cohort study","volume":"23","author":"Estenssoro","year":"2019","journal-title":"Crit Care"},{"key":"10.1016\/j.vaccine.2026.128773_bb0105","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1097\/INF.0000000000004878","article-title":"Maternal Immunization With RSVpreF Vaccine: Effectiveness in Preventing Respiratory Syncytial Virus-associated Hospitalizations in Infants Under 6 Months in Argentina: Multicenter Case-control Study","volume":"44","author":"Gentile","year":"2025","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2026.128773_bb0110","doi-asserted-by":"crossref","unstructured":"McLachlan I, Robertson C, Morrison KE, et al. Effectiveness of the maternal RSVpreF vaccine against severe disease in infants in Scotland, UK: a national, population-based case\u2013control study and cohort analysis. Lancet Infect Dis 2025; 0. DOI:https:\/\/doi.org\/10.1016\/S1473-3099(25)00624-3.","DOI":"10.1016\/S1473-3099(25)00624-3"},{"key":"10.1016\/j.vaccine.2026.128773_bb0115","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1097\/INF.0000000000001580","article-title":"The Residual Vaccine-preventable Burden of Rotavirus Disease","volume":"36","author":"Sederdahl","year":"2017","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2026.128773_bb0120","doi-asserted-by":"crossref","first-page":"S154","DOI":"10.1093\/cid\/ciw526","article-title":"Incidence of Severe and Nonsevere Pertussis Among HIV-Exposed and -Unexposed Zambian Infants Through 14 Weeks of Age: Results From the Southern Africa Mother Infant Pertussis Study (SAMIPS), a Longitudinal Birth Cohort Study","volume":"63","author":"Gill","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2026.128773_bb0125","first-page":"13","article-title":"A population database analysis to describe the residual burden of varicella in Italy\u2014a high vaccination coverage area\u2014from 2004 to 2022","author":"Barbieri","year":"2025","journal-title":"Front Public Health"},{"key":"10.1016\/j.vaccine.2026.128773_bb0130","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2025.44679","article-title":"Nirsevimab Prophylaxis and Respiratory Syncytial Virus Hospitalizations Among Infants","volume":"8","author":"Cocchi","year":"2025","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.vaccine.2026.128773_bb0135","doi-asserted-by":"crossref","unstructured":"Mazur NI, Caballero MT, Nunes MC. Severe respiratory syncytial virus infection in children: burden, management, and emerging therapies. Lancet 2024; 0. DOI:https:\/\/doi.org\/10.1016\/S0140-6736(24)01716-1.","DOI":"10.1016\/S0140-6736(24)01716-1"},{"key":"10.1016\/j.vaccine.2026.128773_bb0140","doi-asserted-by":"crossref","first-page":"837","DOI":"10.15585\/mmwr.mm7338a2","article-title":"Maternal Respiratory Syncytial Virus Vaccination and Receipt of Respiratory Syncytial Virus Antibody (Nirsevimab) by Infants Aged <8 Months \u2014 United States, April 2024","volume":"73","author":"Razzaghi","year":"2024","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2026.128773_bb0145","first-page":"58","article-title":"Effectiveness of nirsevimab against hospitalisation for RSV-bronchiolitis during high RSV-B circulation in the second year of nationwide implementation in France: a test-negative case-control study","author":"Furgier","year":"2025","journal-title":"Lancet Reg Health \u2013 Eur"},{"key":"10.1016\/j.vaccine.2026.128773_bb0150","doi-asserted-by":"crossref","first-page":"e2165","DOI":"10.1016\/S2214-109X(25)00379-1","article-title":"The path to equitable respiratory syncytial virus prevention for infants: challenges and opportunities for global implementation","volume":"13","author":"Shaaban","year":"2025","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.vaccine.2026.128773_bb0155","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2024-070240","article-title":"Infant Respiratory Syncytial Virus Immunization Coverage in the Vaccine Safety Datalink: 2023\u20132024","volume":"155","author":"Irving","year":"2025","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2026.128773_bb0160","article-title":"Real-world evidence on RSV vaccine uptake, effectiveness, and safety in older adults: a systematic review and meta-analysis","volume":"64","author":"Trusinska","year":"2026","journal-title":"Lancet Reg Health - Eur"},{"key":"10.1016\/j.vaccine.2026.128773_bb0165","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1093\/cid\/ciw397","article-title":"Two Birds With One Stone: Estimating Population Vaccination Coverage From a Test-negative Vaccine Effectiveness Case-control Study","volume":"63","author":"Doll","year":"2016","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"10.1016\/j.vaccine.2026.128773_bb0170","series-title":"Outlines recommendations to protect infants against RSV \u2013 respiratory syncytial virus","author":"WHO","year":"2025"},{"key":"10.1016\/j.vaccine.2026.128773_bb0175","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/s41541-022-00550-5","article-title":"Predicted effectiveness of vaccines and extended half-life monoclonal antibodies against RSV hospitalizations in children","volume":"7","author":"Zheng","year":"2022","journal-title":"Npj Vaccines"},{"key":"10.1016\/j.vaccine.2026.128773_bb0180","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1007\/s40121-025-01193-4","article-title":"Complementary Strategy of Maternal Immunization with RSVpreF Vaccine and Monoclonal Antibodies for the Prevention of Respiratory Syncytial Virus Among Italian Infants: A Cost-Effectiveness Assessment","volume":"14","author":"Polistena","year":"2025","journal-title":"Infect Dis Ther"},{"key":"10.1016\/j.vaccine.2026.128773_bb0185","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1001\/jamapediatrics.2024.5572","article-title":"Respiratory Syncytial Virus Disease Burden and Nirsevimab Effectiveness in Young Children From 2023-2024","volume":"179","author":"Moline","year":"2025","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.vaccine.2026.128773_bb0190","author":"World Health Organization"},{"key":"10.1016\/j.vaccine.2026.128773_bb0195","article-title":"Cost-effectiveness analysis of nirsevimab and maternal RSVpreF vaccine strategies for prevention of Respiratory Syncytial Virus disease among infants in Canada: a simulation study","volume":"28","author":"Shoukat","year":"2023","journal-title":"Lancet Reg Health Am"},{"key":"10.1016\/j.vaccine.2026.128773_bb0200","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S2213-2600(22)00414-3","article-title":"The burden of respiratory syncytial virus in healthy term-born infants in Europe: a prospective birth cohort study","volume":"11","author":"Wildenbeest","year":"2023","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.vaccine.2026.128773_bb0205","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1164\/rccm.201603-0658OC","article-title":"Mortality due to Respiratory Syncytial Virus. Burden and Risk Factors","volume":"195","author":"Geoghegan","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.vaccine.2026.128773_bb0210","year":"2026","journal-title":"Argentina.gob.ar."},{"key":"10.1016\/j.vaccine.2026.128773_bb0215","article-title":"The full value of immunisation against respiratory syncytial virus for infants younger than 1 year: effects beyond prevention of acute respiratory illness","volume":"S1473-3099(23)","author":"Feikin","year":"2023","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2026.128773_bb0220","first-page":"52","article-title":"Respiratory syncytial virus prevention in infants and equity in Latin America and the Caribbean: from evidence to action","author":"Avila-Aguero","year":"2025","journal-title":"Lancet Reg Health \u2013 Am"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26005827?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26005827?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T19:28:15Z","timestamp":1783106895000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X26005827"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":44,"alternative-id":["S0264410X26005827"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128773","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Residual burden of severe RSV disease in infants during the first season of maternal RSVpreF immunization in Argentina: A hospital-based, multicentre, retrospective cohort study","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128773","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"128773"}}